CVRx, Inc. (CVRX) Reports In-Line Q2 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. LRCX
7. LVS
8. CSX
9. QGEN
10. KNX

Go back to CVRx, Inc. (CVRX) Reports In-Line Q2 EPS

CVRx Reports Second Quarter 2022 Financial and Operating Results

July 28, 2022 4:10 PM EDT

MINNEAPOLIS, July 28, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (CVRx), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the second quarter of 2022.

Recent Highlights

Total revenue for the second quarter 2022 was $5.0 million, an increase of 61% over prior year quarterU.S. Heart Failure (HF) revenue for the second quarter of 2022 was $3.8 million, an increase of 90% over prior year... More